A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome

Completed · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Post-Lyme Disease Syndrome (PLDS)

In brief

This study will determine the effectiveness of a nutraceutical in treating the lingering effects of Lyme Disease after antibiotic treatment.

Key facts

Study ID

NCT04141969

Run by

Optimal Health Research

People needed

100

Starts

2019-11-29

Expected to finish

2021-03-28

Last updated by the study team

2021-04-12

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A positive two-test methodology using a sensitive enzyme immunoassay (EIA) or immunofluorescence assay as a first test, followed by a western immunoblot assay for specimens yielding positive or equivocal results for Lyme Disease that has been treated with antibiotics but the symptoms persist post treatment.
• Must be able to swallow a mixed powder drink.

You may not qualify if…

• 1 .Non Positive Western Blot test.
• Positive Western Blot test where the individual has not been treated with antibiotics.

Where it is running

• Optimal Health Research — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.